Recall Record

San Diego, CA, United States

Hologic, Inc recalls

29 recalls recorded since 2018, most recently on 8 April 2026. 22 are listed as ongoing. Status and classification are as published by the FDA.

Recalls29
Ongoing (FDA)22
Terminated or completed7
Class I (FDA)2

Ongoing Class II Medical devices

Recall started
8 April 2026
Reason
Complaints have been received of systems developing loose, missing, or broken internal bolts over time.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2167-2026, Z-2168-2026

Ongoing Class II Medical devices

Recall started
23 March 2026
Reason
It was identified that certain devices were being operated outside the validated and FDA-cleared display configuration due to user modification of the manufacturer-installed settings. Modifications included disabling Barco Application Appearance Manager (AAM), altering calibration and compliance parameters, and adjusting additional display-related settings. This field correction is being conducted to restore affected system to the validated configuration and reinforce proper use in accordance with the Operator's Manual.
Distribution
Worldwide distribution - US Nationwide and the countries of Asia Pacific, Europe, and the Middle East.
Initiated
Voluntary: Firm initiated
Recall number
Z-1949-2026

Ongoing Class II Medical devices

Recall started
18 February 2026
Reason
Due to product exhibiting potential to generate either invalid or false negative results.
Distribution
U.S. Nationwide distribution in the states of CA, FL. IA, IL, MO, NC, NM, PR, and TN.
Initiated
Voluntary: Firm initiated
Recall number
Z-1586-2026

Ongoing Class II Medical devices

Recall started
15 December 2025
Reason
Presence of particulates in affected devices that can be deposited into breast tissue during use.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1314-2026

Ongoing Class II Medical devices

Recall started
12 December 2025
Reason
Fungal contamination of affected lot with Parengyodontium album.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1093-2026

Ongoing Class II Medical devices

Recall started
15 January 2025
Reason
Devices presented a condition in which the inner needle separated from the hub and produced a longer throw of the inner needle or dislodgement.
Distribution
Domestic: Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-1170-2025

Ongoing Class II Medical devices

Recall started
8 January 2025
Reason
Three lots of Rapid fFN Specimen Collection kit (901164, 901165, and 904850) contain Rapid fFN Specimen Collection Tubes which may be empty, underfilled, or overfilled with extraction buffer. The transport tubes are used with the Fetal Fibronectin Enzyme Immunoassay and Rapid fFN¿ for the TLiIQ¿ System which aids in assessing the risk of preterm delivery. The use of empty transport tubes or transport tubes containing insufficient extraction buffer volume may result in invalid results and/or delays in obtaining results. Additionally, the use of underfilled tubes may result in false positive results and the use of overfilled tubes may result in false negative results.
Distribution
Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, Guam and the countries of Canada and Japan.
Initiated
Voluntary: Firm initiated
Recall number
Z-1095-2025

Ongoing Class II Medical devices

Recall started
13 December 2024
Reason
Potential weak pouch seal on Panther Fusion GBS assay cartridge, causing potential for invalid or incorrect results leading to a possible delay of treatment.
Distribution
AR, CA, CT, FL, IN, KS, LA, MA, ME, MI, NC, NJ, NV, NY, PR, TX, UT, VT, WA, WV, and Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-0907-2025

Ongoing Class II Medical devices

Recall started
8 November 2024
Reason
SARS-CoV-2/Flu A/B/RSV Assay Kit may erroneously produce SARS-CoV-2 false positive results.
Distribution
US: AK
Initiated
Voluntary: Firm initiated
Recall number
Z-0694-2025

Ongoing Class I Medical devices

Recall started
10 October 2024
Reason
Firm received reports of adverse events/complications that include serious injuries, such as pain, infection, rash, device migration, device erosion, seroma, and discomfort.
Distribution
Domestic: US Nationwide Distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0328-2025

Ongoing Class II Medical devices

Recall started
19 August 2024
Reason
Identified an issue with Selenia Dimensions 1.12.0 and 3Dimensions 2.3.0 system software when used in combination with C-View software in which the quality of the final C-View synthesized 2D image is impacted and may appear blurry and result in misdiagnosis with the possibility being a false negative diagnosis
Distribution
Worldwide distribution - US Nationwide and the countries of Belgium, Canada, Israel, Korea, Republic of, Netherlands.
Initiated
Voluntary: Firm initiated
Recall number
Z-3248-2024

Ongoing Class II Medical devices

Recall started
13 June 2024
Reason
Non-conformance pertains to electromagnetic compatibility requirements according to the international technical standard IEC 60601-1-2 for the safety and essential performance of medical electrical equipment, where the result from the Horizon DXA System exceeded the limit for acceptability.
Distribution
Worldwide distribution - US Nationwide and the countries of India, Australia, Spain, Estonia, Germany, Italy, Canada, Thailand, Dominican Republic, Portugal, Islas Canarias, Andorra, Switzerland, Taiwan, Austria, Korea, Republic of Philippines, Kuwait, Slovakia, China, Belgium, Ireland, United Kin
Initiated
Voluntary: Firm initiated
Recall number
Z-2373-2024

Ongoing Class I Medical devices

Recall started
13 March 2024
Reason
Safety Information: Complaints describe complications/adverse events that include pain, infection, rash, device migration, device erosion, seroma, discomfort, or other complications from feeling the device in the breast, and the need for additional medical treatment to remove the device
Distribution
US Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-1733-2024

Ongoing Class II Medical devices

Recall started
15 December 2023
Reason
Due to potential false positive Flu B results when a sample was also SARS-CoV-2 positive.
Distribution
Worldwide - U.S. Nationwide distribution including in the states of AK, AR, CA, CO, CT, FL, IL, IN, MA, ME, MI, MN, MO, MT, NC, ND, NH, NJ, NM, NV, NY, OH, PA, Puerto Rico, TX, UT, VA, VI, WA, WI, and WV. The countries of Austria, Australia, Belgium, Dominican Republic, Switzerland, Germany, Denmark
Initiated
Voluntary: Firm initiated
Recall number
Z-0782-2024

Ongoing Class II Medical devices

Recall started
14 September 2023
Reason
Use of assay along with plasma specimen may result in error code which would invalidate sample.
Distribution
Worldwide - US Nationwide distribution in the states of CA, CT, FL, ID, IL, MD, MI, MO, TN, TX, WI and the countries of Australia, Germany, Denmark, Spain, France, Great Britain, Italy, Norway, Qatar, Sweden.
Initiated
Voluntary: Firm initiated
Recall number
Z-1371-2024

Ongoing Class II Medical devices

Recall started
2 May 2023
Reason
The inner needle of the Sertera device is either detaching or discharging and may cause delay in surgery
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2035-2023

Ongoing Class II Medical devices

Recall started
16 January 2023
Reason
C-Arm unexpected movement may cause blunt trauma should the tube arm impinge upon an individual
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1144-2023

Completed Class II Medical devices

Recall started
10 October 2022
Reason
IFU was not provided with the Sizer Set sterilization tray Revised Sterilization Instructions for Sizer Set
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0669-2025

Ongoing Class II Medical devices

Recall started
9 August 2022
Reason
Hologic BioZorb LP Marker, (Product number F0221), lot number 22A0RL, contained removable labels with an expiration date that indicated the product had already expired. The expiration date on the removable label is actually manufacturing date, and it's different from the one on the shelf box label, which is the correct expiration date.
Distribution
US Nationwide distribution including in the states of FL, IL, MD, NJ, AZ, TX, WA, VA, OK, NC, NH, GA, CA, CT, OH, CO, MI, MO, KS, TN, ID, MS, MT, AL, OR, IA, PA, MA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1858-2022

Ongoing Class II Medical devices

Recall started
18 March 2022
Reason
Samples, run on a GBS Assay, that have analyte concentrations that are at or near the limit of detection may produce false negative results.
Distribution
US: TX, TN, NY, NV, IN, AR, CA, CT, IL, NH, PA, WA, FL, OR, WV, VA, UT, MA, NJ, MI, PR OUS: CA
Initiated
Voluntary: Firm initiated
Recall number
Z-0877-2022

Ongoing Class II Medical devices

Recall started
27 January 2022
Reason
Failed stability specifications for reagent kits that may result in false negative test results.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AR, CA, CT, FL, GA, ID, IL, IN, MA, MD, ME, MI, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WI, WV, District of Columbia and the countries of Canada, Australia, Belgium, Netherlands, China, Italy, Germany, Sweden.
Initiated
Voluntary: Firm initiated
Recall number
Z-0750-2022

Ongoing Class II Medical devices

Recall started
26 February 2021
Reason
There is a potential for tube trays to leak which could potentially result in false positive results, false negative results or invalid patient results.
Distribution
Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CT, DC, FL, GA, HI, IL, IN, MA, MD, ME, MI, MN, MO, NC, NH, NJ, NY, OH, OR, PA, TX, UT, VA, VT, WA, WI, WV and the countries of Austria (AT), Belgium (BE), France (FR), Germany (DE), Great Britain (GB), Italy (I
Initiated
Voluntary: Firm initiated
Recall number
Z-1369-2021

Terminated Class II Medical devices

Recall started
4 August 2020
Terminated
23 December 2024
Reason
Tube trays may leak which could invalidate patient results or assay worklists, causing delayed results for any assays with which they are used. A possibility exists of false negative result with flu A/B/RSV assay or paraflu assay.
Distribution
U.S. :ID, SC, VT, CA, IL, UT, NJ, MA, TX, AL, CO, FL, ME, NY, VA, WA, WI, OR, DC, GA, NC, HI, CT, OK, TN, O.U.S.: CA, SE, GB, DE, DO, IT, ES, NO, BE, NL, FR, DK, AT
Initiated
Voluntary: Firm initiated
Recall number
Z-2990-2020

Terminated Class II Medical devices

Recall started
21 January 2020
Terminated
11 August 2021
Reason
The recalling firm has received reports from the field of the C-arm on the Selenia Dimensions system seizing or dropping during field repairs and cleaning of the systems.
Distribution
Domestic distribution to 14 states: AK AZ CA CO CT DC FL GA IA ID IL MA MO NC NH NJ NY OH SD TX VA. Foreign distribution to Italy, United Kingdom, Saudi Arabia, Brazil, Costa Rica, Spain, Canada, Cyprus, Germany, France, Korea, Kuwait, The Netherlands, Oman, Peru, and Russia.
Initiated
Voluntary: Firm initiated
Recall number
Z-1343-2020

Ongoing Class II Medical devices

Recall started
10 October 2019
Reason
Reagent component included in flu test kit may cause both high background signal in a true negative sample leading to false positive and/or false negative results. This could result in false positive and/or false negative results on patient samples or failed controls leading to invalid runs. This could result in incorrect results being reported and a delay in treatment.
Distribution
US: AR, CA, FL, ID, IL, IN, LA, NM, NY, PA, TX, UT, VI, WA, WI OUS: AU, CA
Initiated
Voluntary: Firm initiated
Recall number
Z-2163-2020

Terminated Class II Medical devices

Recall started
6 December 2018
Terminated
24 April 2020
Reason
Calibration issue not possible to visualize contrast uptake in the subtracted mammography images
Distribution
Nationwide Foreign: Australia Austria Belgium Brazil Canada China Colombia Ecuador Egypt France Germany Greece Hong Kong India Ireland Israel Italy Japan Korea, Republic of Kuwait Malaysia Mexico Netherlands Pakistan Peru Poland Portugal Saudi Arabia Singapore Slovakia
Initiated
Voluntary: Firm initiated
Recall number
Z-0685-2019

Terminated Class II Medical devices

Recall started
20 January 2018
Terminated
28 July 2022
Reason
The Panther or the Panther Fusion glass panel separates from the 19 inch touch screen monitor and could potentially fall and hit an operator.
Distribution
Worldwide distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-0595-2018

Terminated Class II Medical devices

Recall started
29 November 2017
Terminated
22 August 2018
Reason
Rapid fFN cassettes were manufactured with material (A137 ascites) from a new supplier (SDIX). The products were distributed to customers before FDA approved the change to use the material from SDIX.
Distribution
United States (US), Guam (GU), Japan (JP)
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0676-2018, Z-0677-2018

Terminated Class II Medical devices

Recall started
7 July 2017
Terminated
4 April 2018
Reason
The firm is implementing a product correction involving its Affirm¿ Lateral Arm Upright Biopsy Accessory, ASY-09880. The correction has been initiated due to a component (the Left-hand Guide or the Blue Needle Guide) issue that could impact needle alignment for all the left-approach lateral biopsy procedures. This may have an impact on the position of the needle within the breast, and thus on the aspiration of the intended tissue. This impact is case-dependent and detectable when imagining is used to confirm needle position and/or tissue acquisition during and after a procedure. There are no known instances of illness or injury.
Distribution
US and OUS
Initiated
Voluntary: Firm initiated
Recall number
Z-0351-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.